These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Cannabinoid Effect and Safety in Spasticity Following Stroke: A Double-Blind Randomized Placebo-Controlled Study. Marinelli L; Puce L; Mori L; Leandri M; Rosa GM; Currà A; Fattapposta F; Trompetto C Front Neurol; 2022; 13():892165. PubMed ID: 35812088 [TBL] [Abstract][Full Text] [Related]
29. Development of an integrated conceptual model of multiple sclerosis spasticity. Cameron MH; Bethoux F; Field-Fote E; Lenderking WR; Zaiser E; Cutts KN; Wagner JM; Berwaerts J; Steinerman JR Disabil Rehabil; 2024 Jun; 46(13):2955-2965. PubMed ID: 37480330 [TBL] [Abstract][Full Text] [Related]
30. Safety and tolerability of nabiximols oromucosal spray: a review of more than 15 years" accumulated evidence from clinical trials. Prieto González JM; Vila Silván C Expert Rev Neurother; 2021 Jul; 21(7):755-778. PubMed ID: 34092180 [No Abstract] [Full Text] [Related]
31. A Novel, Integrative Approach for Evaluating Progression in Multiple Sclerosis: Development of a Scoring Algorithm. Tolley C; Piani-Meier D; Bentley S; Bennett B; Jones E; Pike J; Dahlke F; Tomic D; Ziemssen T JMIR Med Inform; 2020 Apr; 8(4):e17592. PubMed ID: 32286236 [TBL] [Abstract][Full Text] [Related]
32. Effect of Sativex on spasticity-associated symptoms in patients with multiple sclerosis. Meuth SG; Vila C; Dechant KL Expert Rev Neurother; 2015; 15(8):909-18. PubMed ID: 26166264 [TBL] [Abstract][Full Text] [Related]
33. A Cross-Sectional Study of the Impact of Spasticity on Daily Activities in Multiple Sclerosis. Bethoux F; Marrie RA Patient; 2016 Dec; 9(6):537-546. PubMed ID: 27154536 [TBL] [Abstract][Full Text] [Related]
34. Managing the symptoms of multiple sclerosis: a multimodal approach. Crayton HJ; Rossman HS Clin Ther; 2006 Apr; 28(4):445-60. PubMed ID: 16750459 [TBL] [Abstract][Full Text] [Related]
35. Getting the measure of spasticity in multiple sclerosis: the Multiple Sclerosis Spasticity Scale (MSSS-88). Hobart JC; Riazi A; Thompson AJ; Styles IM; Ingram W; Vickery PJ; Warner M; Fox PJ; Zajicek JP Brain; 2006 Jan; 129(Pt 1):224-34. PubMed ID: 16280352 [TBL] [Abstract][Full Text] [Related]
36. Efficacy and safety of nabiximols (Sativex(®)) on multiple sclerosis spasticity in a real-life Italian monocentric study. Ferrè L; Nuara A; Pavan G; Radaelli M; Moiola L; Rodegher M; Colombo B; Keller Sarmiento IJ; Martinelli V; Leocani L; Martinelli Boneschi F; Comi G; Esposito F Neurol Sci; 2016 Feb; 37(2):235-42. PubMed ID: 26474875 [TBL] [Abstract][Full Text] [Related]
37. Pathophysiology, assessment and management of multiple sclerosis spasticity: an update. Haas J Expert Rev Neurother; 2011 Apr; 11(4 Suppl):3-8. PubMed ID: 21449853 [TBL] [Abstract][Full Text] [Related]